Synthetic gene for the hepatitis C virus nucleocapsid protein
A synthetic gene encoding the hepatitis C virus (HCV) nucleocapsid protein was constructed and expressed in E.coli. To synthesize this gene, we developed a new method that results in the enzymatic synthesis of long polydeoxyribonucleotides from oligodeoxy-ribonucleotides. The method, designated as t...
Saved in:
Published in | Nucleic acids research Vol. 21; no. 11; pp. 2747 - 2754 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
11.06.1993
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A synthetic gene encoding the hepatitis C virus (HCV) nucleocapsid protein was constructed and expressed in E.coli. To synthesize this gene, we developed a new method that results in the enzymatic synthesis of long polydeoxyribonucleotides from oligodeoxy-ribonucleotides. The method, designated as the ‘Exchangeable Template Reaction’ (ETR), uses oligonucleotides as templates for DNA polymerase. A special mechanism was designed to exchange the templates during the polymerase reaction. The mechanism relies on the formation of a single-stranded 3′-protrusion at the ‘growing point’ of the elongating DNA such that it can be subsequently annealed, in a sequence-specific manner, with the next synthetic oligonucleotide. When annealed to the 3′-protrusion, the added oligonucleotide becomes a template for DNA polymerase, and the protruding 3′-end of the double-stranded DNA is used as the primer. The HCV nucleocapsid gene was assembled with DNA ligase from three fragments synthesized by ETR. The data verify that this method is efficient. The main advantage of ETR is the ability to combine more than two oligonucleotides in one tube together with polymerase and an enzymatic activity that produces a 3′-protrusion (e.g., BstXI) rather than the sequential addition of each component. The data demonstrate that as many as five oligonucleotides can be used simultaneously, resulting in a synthesized DNA fragment of designed sequence. The synthetic gene expressed in E.coli produced a 27kDa protein that specifically interacted with antibodies from sera obtained from HCV-infected individuals. |
---|---|
Bibliography: | istex:B5B64BE4966F8F4800408C902E626511B6A5F90F ArticleID:21.11.2747 To whom correspondence should be addressed at: Hepatitis Branch, National Center for infectious Diseases, Centers for Disease Control, 1600 Clifton Rd, Atlanta, GA 30333, USA ark:/67375/HXZ-BDC9B0CK-J ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0305-1048 1362-4962 |
DOI: | 10.1093/nar/21.11.2747 |